Aspergillus -associated airway disease, inflammation, and the innate immune response

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Chotirmall, Sanjay H ^a   Al Alawi, Mazen ^a   Mirkovic, Bojana ^a   Lavelle, Gillian ^a   Logan, P Mark ^a   Greene, Catherine M ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; COMPLEMENT COMPONENT C2; CORTICOSTEROID; CXCL1 CHEMOKINE; CXCL13 CHEMOKINE; DECTIN 1; GALACTOMANNAN; GLUCOCORTICOID; IMMUNOGLOBULIN G; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; ITRACONAZOLE; LECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANNOSE RECEPTOR; OMALIZUMAB; PATTERN RECOGNITION RECEPTOR; PENTRAXIN 3; POLYPEPTIDE ANTIBIOTIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTIFICIAL EMBOLISM; ASPERGILLUS; BRONCHIECTASIS; CELL COMMUNICATION; CHRONIC GRANULOMATOUS DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DENDRITIC CELL; GENE EXPRESSION; HEMOPTYSIS; HUMAN; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS MACROPHAGE; LUNG ASPERGILLOSIS; LUNG RESECTION; NEUTROPHIL; PHAGOCYTOSIS; REVIEW; THORAX RADIOGRAPHY; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; LUNG; MICROBIOLOGY; PNEUMONIA;

ANIMALS; ASPERGILLUS; HUMANS; IMMUNITY, INNATE; LUNG; MODELS, IMMUNOLOGICAL; PNEUMONIA; PULMONARY ASPERGILLOSIS;

EID: 84881511917     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/723129     Document Type: Review

References (170)

1. Bardana E. J. Jr., The clinical spectrum of aspergillosis-part 1: epidemiology, pathogenicity, infection in animals and immunology of Aspergillus. Critical Reviews in Clinical Laboratory Sciences 1981 13 1 21 83 2-s2.0-0019399626
2. Cramer R. A., Rivera A., Hohl T. M., Immune responses against Aspergillus fumigatus: what have we learned? Current Opinion in Infectious Diseases 2011 24 4 315 322 2-s2.0-79960248786 10.1097/QCO.0b013e328348b159
3. Greenberger P. A., Allergic bronchopulmonary aspergillosis. Journal of Allergy and Clinical Immunology 2002 110 5 685 692 2-s2.0-0036858609 10.1067/mai.2002.130179 (Pubitemid 35423169)
4. Greenberger P. A., Clinical aspects of allergic bronchopulmonary aspergillosis. Frontiers in Bioscience 2003 8 s119 s127 2-s2.0-3142757353 (Pubitemid 38925406)
5. Kauffman H. F., Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Frontiers in Bioscience 2003 8 e190 e196 2-s2.0-0348025419
6. Tokarski C., Hummert S., Mech F., Agent-based modeling approach of immune defense against spores of opportunistic human pathogenic fungi. Frontiers in Microbiology 2012 3 129
7. Araujo R., Rodrigues A. G., Variability of germinative potential among pathogenic species of Aspergillus. Journal of Clinical Microbiology 2004 42 9 4335 4337 2-s2.0-4644296433 10.1128/JCM.42.9.4335-4337.2004 (Pubitemid 39296172)
8. Krishnan S., Manavathu E. K., Chandrasekar P. H., Aspergillus flavus: an emerging non- fumigatus Aspergillus species of significance. Mycoses 2009 52 3 206 222 2-s2.0-63849275754 10.1111/j.1439-0507.2008.01642.x
9. Osherov N., Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells. Frontiers in Microbiology 2012 3 346
10. Ben-Ami R., Lewis R. E., Kontoyiannis D. P., Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. British Journal of Haematology 2010 150 4 406 417 2-s2.0-77955148951 10.1111/j.1365-2141.2010.08283.x
11. McCormick A., Loeffler J., Ebel F., Aspergillus fumigatus: contours of an opportunistic human pathogen. Cellular Microbiology 2010 12 11 1535 1543 2-s2.0-78650843891 10.1111/j.1462-5822.2010.01517.x
12. Knutsen A. P., Slavin R. G., Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clinical and Developmental Immunology 2011 2011 13 2-s2.0-79959269910 10.1155/2011/843763 843763
13. Hope W. W., Kruhlak M. J., Lyman C. A., Petraitiene R., Petraitis V., Francesconi A., Kasai M., Mickiene D., Sein T., Peter J., Kelaher A. M., Hughes J. E., Cotton M. P., Cotten C. J., Bacher J., Tripathi S., Bermudez L., Maugel T. K., Zerfas P. M., Wingard J. R., Drusano G. L., Walsh T. J., Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. The Journal of Infectious Diseases 2007 195 3 455 466 2-s2.0-33846450646 (Pubitemid 46146125)
14. Thompson G. R. III, Patterson T. F., Pulmonary aspergillosis: recent advances. Seminars in Respiratory and Critical Care Medicine 2011 32 6 673 681 10.1055/s-0031-1295715
15. Verweii P., Brandt M., Murray P., Barron E., Landry M., Jorgenesen J., Aspergillus, Fusarium, and other opportunistic moniliacenous fungi. Manual of Clinical Microbiology 2007 9th Washington, DC, USA ASM Press 1802
16. Neofytos D., Horn D., Anaissie E., Steinbach W., Olyaei A., Fishman J., Pfaller M., Chang C., Webster K., Marr K., Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry. Clinical Infectious Diseases 2009 48 3 265 273 2-s2.0-58749083534 10.1086/595846
17. Kontoyiennis D. P., Marr K. A., Park B. J., Alexander B. D., Anaissie E. J., Walsh T. J., Ito J., Andes D. R., Baddley J. W., Brown J. M., Brumble L. M., Freifeld A. G., Hadley S., Herwaldt L. A., Kauffman C. A., Knapp K., Lyon G. M., Morrison V. A., Papanicolaou G., Patterson T. F., Perl T. M., Schuster M. G., Walker R., Wannemuehler K. A., Wingard J. R., Chiller T. M., Pappas P. G., Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant- associated infection surveillance network (TRANSNET) database. Clinical Infectious Diseases 2010 50 8 1091 1100 2-s2.0-77950280868 10.1086/651263
18. Johkoh T., Muller N. L., Akira M., Ichikado K., Suga M., Ando M., Yoshinaga T., Kiyama T., Mihara N., Honda O., Tomiyama N., Nakamura H., Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000 216 3 773 780 2-s2.0-0033846135 (Pubitemid 30660853)
19. Agarwal R., Gupta D., Aggarwal A. N., Saxena A. K., Chakrabarti A., Jindal S. K., Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007 132 4 1183 1190 2-s2.0-35448968896 10.1378/chest.07-0808 (Pubitemid 47620991)
20. Pfeiffer C. D., Fine J. P., Safdar N., Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clinical Infectious Diseases 2006 42 10 1417 1427 2-s2.0-33646464211 10.1086/503427
21. Clancy C. J., Jaber R. A., Leather H. L., Wingard J. R., Staley B., Wheat L. J., Cline C. L., Rand K. H., Schain D., Baz M., Nguyen M. H., Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. Journal of Clinical Microbiology 2007 45 6 1759 1765 2-s2.0-34250676905 10.1128/JCM.00077-07 (Pubitemid 46933903)
22. Verweij P. E., Latge J. P., Rijs A. J. M. M., Melchers W. J. G., de Pauw B. E., Hoogkamp-Korstanje J. A. A., Meis J. F. G. M., Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. Journal of Clinical Microbiology 1995 33 12 3150 3153 2-s2.0-0028799178
23. Avni T., Levy I., Sprecher H., Yahav D., Leibovici L., Paul M., Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. Journal of Clinical Microbiology 2012 50 11 3652 3658 10.1128/JCM.00942-12
24. Meier A., Kirschning C. J., Nikolaus T., Wagner H., Heesemann J., Ebel F., Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus -induced activation of murine macrophages. Cellular Microbiology 2003 5 8 561 570 2-s2.0-0043198157 10.1046/j.1462-5822.2003.00301.x (Pubitemid 36939595)
25. Netea M. G., Warris A., van der Meer J. W. M., Fenton M. J., Verver-Janssen T. J. G., Jacobs L. E. H., Andresen T., Verweij P. E., Kullberg B. J., Aspergillus fumigatus evades immune recognition during germination through loss of Toll-like receptor-4-mediated signal transduction. The Journal of Infectious Diseases 2003 188 2 320 326 2-s2.0-0041814629 10.1086/376456 (Pubitemid 36898166)
26. Steele C., Rapaka R. R., Metz A., Pop S. M., Williams D. L., Gordon S., Kolls J. K., Brown G. D., The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathogens 2005 1 4, article e42 2-s2.0-33644843975 10.1371/journal.ppat.0010042
27. Chai L. Y. A., Vonk A. G., Kullberg B. J., Verweij P. E., Verschueren I., van der Meer J. W. M., Joosten L. A. B., Latgé J.-P., Netea M. G., Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses. Microbes and Infection 2011 13 2 151 159 2-s2.0-78651504883 10.1016/j.micinf.2010.10.005
28. Balloy V., Sallenave J. M., Wu Y., Touqui L., Latgé J.-P., Si-Tahar M., Chignard M., Aspergillus fumigatus -induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the Toll-like receptor-MyD88 pathway. The Journal of Biological Chemistry 2008 283 45 30513 30521 2-s2.0-57649233054 10.1074/jbc.M803149200
29. Luther K., Torosantucci A., Brakhage A. A., Heesemann J., Ebel F., Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cellular Microbiology 2007 9 2 368 381 2-s2.0-33846246302 10.1111/j.1462-5822. 2006.00796.x (Pubitemid 46092166)
30. Werner J. L., Metz A. E., Horn D., Schoeb T. R., Hewitt M. M., Schwiebert L. M., Faro-Trindade I., Brown G. D., Steele C., Requisite role for the dectin-1 β -glucan receptor in pulmonary defense against Aspergillus fumigatus. The Journal of Immunology 2009 182 8 4938 4946 2-s2.0-65249187409 10.4049/jimmunol.0804250
31. Forlenza M., Scharsack J. P., Kachamakova N. M., Taverne-Thiele A. J., Rombout J. H. W. M., Wiegertjes G. F., Differential contribution of neutrophilic granulocytes and macrophages to nitrosative stress in a host-parasite animal model. Molecular Immunology 2008 45 11 3178 3189 2-s2.0-43649085618 10.1016/j.molimm.2008.02.025
32. Dagenais T. R., Keller N. P., Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clinical Microbiology Reviews 2009 22 3 447 465 10.1128/CMR.00055-08
33. Romani L., Immunity to fungal infections. Nature Reviews Immunology 2011 4 11 24 10.1038/nri1255
34. Abramson S., The air crescent sign. Radiology 2001 218 1 230 232 (Pubitemid 32151300)
35. McCarthy D. S., Pepys J., Pulmonary aspergilloma-clinical immunology. Clinical & Experimental Allergy 1973 3 1 57 70 10.1111/j.1365-2222.1973. tb01310.x
36. Akbari J. G., Varma P. K., Neema P. K., Menon M. U., Neelakandhan K. S., Clinical profile and surgical outcome for pulmonary aspergilloma: a single center experience. Annals of Thoracic Surgery 2005 80 3 1067 1072 2-s2.0-23944518419 10.1016/j.athoracsur.2005.03.078 (Pubitemid 41196817)
37. Lejay A., Falcoz P. E., Santelmo N., Helms O., Kochetkova E., Jeung M., Kessler R., Massard G., Surgery for aspergilloma: time trend towards improved results? Interactive Cardiovascular and Thoracic Surgery 2011 13 4 392 395 2-s2.0-80053046013 10.1510/icvts.2011.265553
38. Swanson K. L., Johnson C. M., Prakash U. B. S., McKusick M. A., Andrews J. C., Stanson A. W., Bronchial artery embolization: experience with 54 patients. Chest 2002 121 3 789 795 2-s2.0-0036204828 10.1378/chest.121.3.789 (Pubitemid 34251443)
39. Giron J., Poey C., Fajadet P., Sans N., Fourcade D., Senac J. P., Railhac J. J., CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. European Journal of Radiology 1998 28 3 235 242 2-s2.0-0032191305 10.1016/S0720-048X(97)00148-4 (Pubitemid 28559202)
40. Henderson A. H., English M. P., Vecht R. J., Pulmonary aspergillosis. A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests. Thorax 1968 23 5 513 518 2-s2.0-0014330345
41. Kramer M. N., Kurup V. P., Fink J. N., Allergic bronchopulmonary aspergillosis from a contaminated dump site. American Review of Respiratory Disease 1989 140 4 1086 1088 2-s2.0-0024444038 (Pubitemid 19259517)
42. Kagen S. L., Kurup V. P., Sohnle P. G., Fink J. N., Marijuana smoking and fungal sensitization. Journal of Allergy and Clinical Immunology 1983 71 4 389 393 2-s2.0-0020630509 (Pubitemid 13124946)
43. Allmers H., Huber H., Baur X., Two year follow-up of a garbage collector with allergic bronchopulmonary aspergillosis [ABPA]. American Journal of Industrial Medicine 2000 37 4 438 442 (Pubitemid 30131580)
44. Hinson K. F., Moon A. J., Plummer N. S., Broncho-pulmonary aspergillosis, a review and a report of eight new cases. Thorax 1952 7 4 317 333 10.1136/thx.7.4.317
45. Beamis J. F., Mark E. J., Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-2001. A 46-year-old woman with chronic sinsusitis, pulmonary nodules, and hemoptysis. The New England Journal of Medicine 2001 345 6 443 449 10.1056/NEJM200108093450608 (Pubitemid 32747608)
46. Rosenberg M., Patterson R., Mintzer R., Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Annals of Internal Medicine 1977 86 4 405 414 2-s2.0-0017353672 (Pubitemid 8078948)
47. Patterson R., Greenberger P. A., Halwig J. M., Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Archives of Internal Medicine 1986 146 5 916 918 2-s2.0-0022656179 (Pubitemid 16116672)
48. Agarwal R., Aggarwal A. N., Gupta D., Jindal S. K., Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. International Journal of Tuberculosis and Lung Disease 2009 13 8 936 944 2-s2.0-62149130396
49. Longbottom J. L., Pepys J., Pulmonary aspergillosis: diagnostic and immunological significance of antigens and C-substance in Aspergillus fumigatus. The Journal of Pathology and Bacteriology 1964 88 141 151 2-s2.0-0001662246
50. Vlahakis N. E., Aksamit T. R., Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clinic Proceedings 2001 76 9 930 938 2-s2.0-0034854083 (Pubitemid 32825915)
51. Greenberger P. A., Allergic bronchopulmonary aspergillosis. Journal of Allergy and Clinical Immunology 1984 74 5 645 653 10.1016/0091-6749(84)90223-9 (Pubitemid 15210988)
52. Wang J. L. F., Patterson R., Rosenberg M., Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. American Review of Respiratory Disease 1978 117 5 917 927 2-s2.0-0018090723 (Pubitemid 8329099)
53. Agarwal R., Singh N., Aggarwal A. N., An unusual association between Mycobacterium tuberculosis and Aspergillus fumigatus. Monaldi Archives for Chest Disease 2008 69 1 32 34 2-s2.0-42549154805 (Pubitemid 351578105)
54. Agarwal R., Srinivas R., Jindal S. K., Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease. Mycoses 2008 51 1 83 85 2-s2.0-36749067880 10.1111/j.1439-0507.2007.01432.x (Pubitemid 350215898)
55. Eppinger T. M., Greenberger P. A., White D. A., Brown A. E., Cunningham-Rundles C., Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. Journal of Allergy and Clinical Immunology 1999 104 6 1265 1272 2-s2.0-0033406125 (Pubitemid 30004990)
56. Mearns M., Young W., Batten J., Transient pulmonary infiltrates in cystic fibrosis due to allergi aspergillosis. Thorax 1965 20 385 392
57. Stevens D. A., Moss R. B., Kurup V. P., Knutsen A. P., Greenberger P., Judson M. A., Denning D. W., Crameri R., Brody A. S., Light M., Skov M., Maish W., Mastella G., Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clinical Infectious Diseases 2003 37 supplement 3 S225 S264 (Pubitemid 37260463)
58. Chotirmall S. H., Branagan P., Gunaratnam C., McElvaney N. G., Aspergillus /allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity. Respiratory Care 2008 53 8 1035 1041 2-s2.0-58149388163
59. McMahon M. A., Chotirmall S. H., McCullagh B., Branagan P., McElvaney N. G., Logan P. M., Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. European Journal of Radiology 2012 81 3 e197 e202 2-s2.0-84856968847 10.1016/j.ejrad.2011.01.114
60. Kirsten D., Nowak D., Rabe K. F., Magnussen H., Diagnosis of bronchopulmonary aspergillosis is often made too late. Medizinische Klinik 1993 88 6 353 356 2-s2.0-0027917532
61. Fairs A., Agbetile J., Hargadon B., Bourne M., Monteiro W. R., Brightling C. E., Bradding P., Green R. H., Mutalithas K., Desai D., Pavord I. D., Wardlaw A. J., Pashley C. H., IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. American Journal of Respiratory and Critical Care Medicine 2010 182 11 1362 1368 2-s2.0-78649874113 10.1164/rccm.201001-0087OC
62. Denning D. W., O'Driscoll B. R., Hogaboam C. M., Bowyer P., Niven R. M., The link between fungi and severe asthma: a summary of the evidence. European Respiratory Journal 2006 27 3 615 626 2-s2.0-32644447957 10.1183/09031936.06. 00074705 (Pubitemid 43372538)
63. Ricketti A. J., Greenberger P. A., Patterson R., Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. Journal of Allergy and Clinical Immunology 1984 74 1 68 71 2-s2.0-0021239305 (Pubitemid 14093028)
64. Imbeau S. A., Nichols D., Flaherty D., Relationships between prednisone therapy, disease activity, and the total serum IgE level in allergic bronchopulmonary aspergillosis. Journal of Allergy and Clinical Immunology 1978 62 2 91 95 2-s2.0-0018078118 (Pubitemid 9003160)
65. Leser C., Kauffman H. F., Virchow C. Sr., Menz G., Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis. Journal of Allergy and Clinical Immunology 1992 90 4, part 1 589 599 2-s2.0-0026701812 10.1016/0091-6749(92)90131-K
66. Agarwal R., Gupta D., Aggarwal A. N., Behera D., Jindal S. K., Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in North India. Chest 2006 130 2 442 448 2-s2.0-33747613125 10.1378/chest.130.2.442 (Pubitemid 44267011)
67. Wark P. A. B., Hensley M. J., Saltos N., Boyle M. J., Toneguzzi R. C., Simpson J. L., McElduff P., Gibson P. G., Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. Journal of Allergy and Clinical Immunology 2003 111 5 952 957 2-s2.0-0038752563 10.1067/mai.2003.1388 (Pubitemid 36570853)
68. Stevens D. A., Schwartz H. J., Lee J. Y., Moskovitz B. L., Jerome D. C., Catanzaro A., Bamberger D. M., Weinmann A. J., Tuazon C. U., Judson M. A., Platts-Mills T. A. E., Degraff A. C. Jr., Grossman J., Slavin R. G., Reuman P., A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. The New England Journal of Medicine 2000 342 11 756 762 2-s2.0-0034673751 10.1056/NEJM200003163421102 (Pubitemid 30151919)
69. Collins J., Devos G., Hudes G., Rosenstreich D., Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. Journal of Asthma and Allergy 2012 5 65 70
70. Coughlan C. A., Chotirmall S. H., Renwick J., The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2012 186 10 999 1007
71. Prfaejf J. A., Fishman's Pulmonary Diseases Disorders 1998 New York, NY, USA McGraw-Hill
72. Rosenberg M., Patterson R., Roberts M., Wang J., The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. The American Journal of Medicine 1978 64 4 599 606 2-s2.0-0018187482 (Pubitemid 8322908)
73. Ricketti A. J., Greenberger P. A., Patterson R., Varying presentations of allergic bronchopulmonary aspergillosis. International Archives of Allergy and Applied Immunology 1984 73 3 283 285 2-s2.0-0021351753 (Pubitemid 14154911)
74. Halwig J. M., Greenberger P. A., Levine M., Patterson R., Recurrence of allergic bronchopulmonary aspergillosis after seven years of remission. Journal of Allergy and Clinical Immunology 1984 74 5 738 740 2-s2.0-0021678988 (Pubitemid 15211000)
75. Lee T. M., Greenberger P. A., Patterson R., Stage V (fibrotic) allergic bronchopulmonary aspergillosis. A review of 17 cases followed from diagnosis. Archives of Internal Medicine 1987 147 2 319 323 2-s2.0-0023121676 (Pubitemid 17040254)
76. Schaffner A., Douglas H., Braude A., Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. The Journal of Clinical Investigation 1982 69 3 617 631 2-s2.0-0020042863 (Pubitemid 12184959)
77. Singh N., Paterson D. L., Aspergillus infections in transplant recipients. Clinical Microbiology Reviews 2005 18 1 44 69 2-s2.0-12944291020 10.1128/CMR.18.1.44-69.2005 (Pubitemid 40173979)
78. Fukuda T., Boeckh M., Carter R. A., Sandmaier B. M., Maris M. B., Maloney D. G., Martin P. J., Storb R. F., Marr K. A., Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003 102 3 827 833 2-s2.0-0042243672 10.1182/blood-2003-02-0456 (Pubitemid 36917771)
79. de Pauw B., Walsh T. J., Donnelly J. P., Stevens D. A., Edwards J. E., Calandra T., Pappas P. G., Maertens J., Lortholary O., Kauffman C. A., Denning D. W., Patterson T. F., Maschmeyer G., Bille J., Dismukes W. E., Herbrecht R., Hope W. W., Kibbler C. C., Kullberg B. J., Marr K. A., Muñoz P., Odds F. C., Perfect J. R., Restrepo A., Ruhnke M., Segal B. H., Sobel J. D., Sorrell T. C., Viscoli C., Wingard J. R., Zaoutis T., Bennett J. E., Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases 2008 46 12 1813 1821 2-s2.0-46249126149 10.1086/588660
80. Tortorano A. M., Esposto M. C., Prigitano A., Grancini A., Ossi C., Cavanna C., Lo Cascio G., Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 2012 50 3 1051 1053 2-s2.0-84857389358 10.1128/JCM.05946-11
81. Wheat L. J., Hackett E., Durkin M., Connolly P., Petraitiene R., Walsh T. J., Knox K., Hage C., Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clinical and Vaccine Immunology 2007 14 5 638 640 2-s2.0-34250331175 10.1128/CVI.00479-06
82. Cornillet A., Camus C., Nimubona S., Gandemer V., Tattevin P., Belleguic C., Chevrier S., Meunier C., Lebert C., Aupée M., Caulet-Maugendre S., Faucheux M., Lelong B., Leray E., Guiguen C., Gangneux J.-P., Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clinical Infectious Diseases 2006 43 5 577 584 2-s2.0-33747616462 10.1086/505870 (Pubitemid 44267116)
83. Stanzani M., Battista G., Sassi C., Lewis R. E., Tolomelli G., Clissa C., Femia R., Bazzocchi A., Tumietto F., Viale P., Ambretti S., Baccarani M., Vianelli N., Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies. Clinical Infectious Diseases 2012 54 5 610 616 2-s2.0-84856891855 10.1093/cid/cir861
84. Limper A. H., Knox K. S., Sarosi G. A., Ampel N. M., Bennett J. E., Catanzaro A., Davies S. F., Dismukes W. E., Hage C. A., Marr K. A., Mody C. H., Perfect J. R., Stevens D. A., An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. American Journal of Respiratory and Critical Care Medicine 2011 183 1 96 128 2-s2.0-78650794568 10.1164/rccm.2008-740ST
85. Walsh T. J., Anaissie E. J., Denning D. W., Herbrecht R., Kontoyiannis D. P., Marr K. A., Morrison V. A., Segal B. H., Steinbach W. J., Stevens D. A., van Burik J.-A., Wingard J. R., Patterson T. F., Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America. Clinical Infectious Diseases 2008 46 3 327 360 2-s2.0-39449095735 10.1086/525258 (Pubitemid 351265310)
86. Herbrecht R., Denning D. W., Patterson T. F., Bennett J. E., Greene R. E., Oestmann J.-W., Kern W. V., Marr K. A., Ribaud P., Lortholary O., Sylvester R., Rubin R. H., Wingard J. R., Stark P., Durand C., Caillot D., Thiel E., Chandrasekar P. H., Hodges M. R., Schlamm H. T., Troke P. F., de Pauw B., Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. The New England Journal of Medicine 2002 347 6 408 415 2-s2.0-0037043655 10.1056/NEJMoa020191 (Pubitemid 34851833)
87. Morton C. O., Bouzani M., Loeffler J., Rogers T. R., Direct interaction studies between Aspergillus fumigatus and human immune cells, what have we learned about pathogenicity and host immunity? Frontiers in Microbiology 2012 3 413
88. Balloy V., Chignard M., The innate immune response to Aspergillus fumigatus. Microbes and Infection 2009 11 12 919 927 2-s2.0-69349103080 10.1016/j.micinf.2009.07.002
89. Latge J. P., Aspergillus fumigatus and aspergillosis. Clinical Microbiology Reviews 1999 12 2 310 350
90. Brakhage A. A., Bruns S., Thywissen A., Zipfel P. F., Behnsen J., Interaction of phagocytes with filamentous fungi. Current Opinion in Microbiology 2010 13 4 409 415 2-s2.0-77955426412 10.1016/j.mib.2010.04.009
91. Ibrahim-Granet O., Philippe B., Boleti H., Boisvieux-Ulrich E., Grenet D., Stern M., Latgé J. P., Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infection and Immunity 2003 71 2 891 903 2-s2.0-0037306194 10.1128/IAI.71.2.891-903.2003 (Pubitemid 36150785)
92. Boot R. G., Renkema G. H., Strijland A., van Zonneveld A. J., Aerts J. M. F. G., Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. The Journal of Biological Chemistry 1995 270 44 26252 26256 2-s2.0-0028799896 10.1074/jbc.270.44.26252
93. Hartl D., He C. H., Koller B., da Silva C. A., Kobayashi Y., Lee C. G., Flavell R. A., Elias J. A., Acidic mammalian chitinase regulates epithelial cell apoptosis via a chitinolytic-independent mechanism. The Journal of Immunology 2009 182 8 5098 5106 2-s2.0-65249168882 10.4049/jimmunol.0803446
94. Wiesner J., Vilcinskas A., Antimicrobial peptides: the ancient arm of the human immune system. Virulence 2010 1 5 440 464 2-s2.0-78249233244 10.4161/viru.1.5.12983
95. Philippe B., Ibrahim-Granet O., Prévost M. C., Gougerot-Pocidalo M. A., Perez M. S., van der Meeren A., Latgé J. P., Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infection and Immunity 2003 71 6 3034 3042 2-s2.0-0037900003 10.1128/IAI.71.6.3034-3042.2003 (Pubitemid 36637524)
96. Bruns S., Kniemeyer O., Hasenberg M., Aimanianda V., Nietzsche S., Thywissen A., Jeron A., Latgé J.-P., Brakhage A. A., Gunzer M., Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathogens 2010 6 4 2-s2.0-77953921805 10.1371/journal.ppat.1000873 e1000873
97. von Köckritz-Blickwede M., Nizet V., Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. Journal of Molecular Medicine 2009 87 8 775 783 2-s2.0-70349263992 10.1007/s00109-009-0481- 0
98. de Smet K., Contreras R., Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnology Letters 2005 27 18 1337 1347 2-s2.0-29144521244 10.1007/s10529-005-0936-5 (Pubitemid 41805626)
99. Alekseeva L., Huet D., Féménia F., Mouyna I., Abdelouahab M., Cagna A., Guerrier D., Tichanné-Seltzer V., Baeza-Squiban A., Chermette R., Latgé J.-P., Berkova N., Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiology 2009 9, article 33 2-s2.0-62149106251 10.1186/1471-2180-9-33
100. Bals R., Wang X., Zasloff M., Wilson J. M., The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of the United States of America 1998 95 16 9541 9546 2-s2.0-0032482980 10.1073/pnas.95.16.9541 (Pubitemid 28506267)
101. Tsai P. W., Yang C. Y., Chang H. T., Lan C. Y., Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 2011 6 3 2-s2.0-79952679401 10.1371/journal.pone.0017755 e17755
102. Bjorstad A., Askarieh G., Brown K. L., The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes. Antimicrobial Agents and Chemotherapy 2009 53 3 1027 1038 10.1128/AAC.01310-08
103. Benincasa M., Scocchi M., Pacor S., Tossi A., Nobili D., Basaglia G., Busetti M., Gennaro R., Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. Journal of Antimicrobial Chemotherapy 2006 58 5 950 959 2-s2.0-39049135214 10.1093/jac/dkl382
104. McKiernan P. J., McElvaney N. G., Greene C. M., SLPI and inflammatory lung disease in females. Biochemical Society Transactions 2011 39 5 1421 1426 2-s2.0-80053371446 10.1042/BST0391421
105. Baranger K., Zani M. L., Chandenier J., Dallet-Choisy S., Moreau T., The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function. FEBS Journal 2008 275 9 2008 2020 2-s2.0-42449120993 10.1111/j.1742-4658.2008.06355.x (Pubitemid 351569543)
106. Garianda C., Hirsch E., Bozza S., Salustri A., de Acetis M., Nota R., Maccagno A., Riva F., Bottazzi B., Peri G., Doni A., Vago L., Botto M., de Santis R., Carminati P., Siracusa G., Altruda F., Vecchi A., Romani L., Mantovani A., Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002 420 6912 182 186 2-s2.0-18744372691 10.1038/nature01195 (Pubitemid 35340122)
107. Jaillon S., Peri G., Delneste Y., Frémaux I., Doni A., Moalli F., Garlanda C., Romani L., Gascan H., Bellocchio S., Bozza S., Cassatella M. A., Jeannin P., Mantovani A., The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. Journal of Experimental Medicine 2007 204 4 793 804 2-s2.0-34247357725 10.1084/jem.20061301 (Pubitemid 46631609)
108. Allen M. J., Harbeck R., Smith B., Voelker D. R., Mason R. J., Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia. Infection and Immunity 1999 67 9 4563 4569 2-s2.0-0032774607 (Pubitemid 29400434)
109. Madan T., Eggleton P., Kishore U., Strong P., Aggrawal S. S., Sarma P. U., Reid K. B. M., Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infection and Immunity 1997 65 8 3171 3179 2-s2.0-0030758115 (Pubitemid 27342395)
110. Allen M. J., Voelker D. R., Mason R. J., Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus. Infection and Immunity 2001 69 4 2037 2044 2-s2.0-0035077414 10.1128/IAI.69.4.2037-2044.2001 (Pubitemid 32239667)
111. Neth O., Jack D. L., Dodds A. W., Holzel H., Klein N. J., Turner M. W., Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infection and Immunity 2000 68 2 688 693 2-s2.0-0033978938 10.1128/IAI.68.2.688-693.2000 (Pubitemid 30056524)
112. Kaur S., Gupta V. K., Thiel S., Sarma P. U., Madan T., Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clinical and Experimental Immunology 2007 148 2 382 389 2-s2.0-34247149839 10.1111/j.1365-2249.2007.03351.x (Pubitemid 46587595)
113. Kozel T. R., Wilson M. A., Farrell T. P., Levitz S. M., Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infection and Immunity 1989 57 11 3412 3417 2-s2.0-0024428511 (Pubitemid 19259870)
114. Sturtevant J. E., Latge J. P., Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infection and Immunity 1992 60 5 1913 1918 2-s2.0-0026681696
115. Hector R. F., Yee E., Collins M. S., Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infection and Immunity 1990 58 5 1476 1478 2-s2.0-0025325921 (Pubitemid 20151819)
116. Washburn R. G., DeHart D. J., Agwu D. E., Bryant-Varela B. J., Julian N. C., Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography. Infection and Immunity 1990 58 11 3508 3515 2-s2.0-0025094604 (Pubitemid 20353345)
117. Behnsen J., Hartmann A., Schmaler J., Gehrke A., Brakhage A. A., Zipfel P. F., The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infection and Immunity 2008 76 2 820 827 2-s2.0-39149139017 10.1128/IAI.01037-07 (Pubitemid 351251755)
118. Wang J. E., Warris A., Ellingsen E. A., Jørgensen P. F., Flo T. H., Espevik T., Solberg R., Verweij P. E., Aasen A. O., Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infection and Immunity 2001 69 4 2402 2406 2-s2.0-0035085495 10.1128/IAI.69.4.2402-2406.2001 (Pubitemid 32239710)
119. Mambula S. S., Sau K., Henneke P., Golenbock D. T., Levitz S. M., Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. The Journal of Biological Chemistry 2002 277 42 39320 39326 2-s2.0-0037131427 10.1074/jbc.M201683200 (Pubitemid 35190904)
120. Ramirez-Ortiz Z. G., Specht C. A., Wang J. P., Lee C. K., Bartholomeu D. C., Gazzinelli R. T., Levitz S. M., Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infection and Immunity 2008 76 5 2123 2129 2-s2.0-42949093707 10.1128/IAI.00047-08 (Pubitemid 351656146)
121. da Silva C. A., Hartl D., Liu W., Lee C. G., Elias J. A., TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. The Journal of Immunology 2008 181 6 4279 4286 2-s2.0-56149127705
122. Serrano-Gómez D., Domínguez-Soto A., Ancochea J., Jimenez-Heffernan J. A., Leal J. A., Corbí A. L., Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. The Journal of Immunology 2004 173 9 5635 5643 2-s2.0-6344268943 (Pubitemid 39392151)
123. Persat F., Noirey N., Diana J., Gariazzo M.-J., Schmitt D., Picot S., Vincent C., Binding of live conidia of Aspergillus fumigatus activates in vitro-generated human Langerhans cells via a lectin of galactomannan specificity. Clinical and Experimental Immunology 2003 133 3 370 377 2-s2.0-0041825496 10.1046/j.1365-2249.2003.02222.x (Pubitemid 37046961)
124. Taylor P. R., Tsoni S. V., Willment J. A., Dennehy K. M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., Brown G. D., Dectin-1 is required for β -glucan recognition and control of fungal infection. Nature Immunology 2007 8 1 31 38 2-s2.0-33846962860 10.1038/ni1408 (Pubitemid 46242356)
125. Gersuk G. M., Underhill D. M., Zhu L., Marr K. A., Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. The Journal of Immunology 2006 176 6 3717 3724 2-s2.0-33644844495 (Pubitemid 43364018)
126. Strieter R. M., Belperio J. A., Keane M. P., Cytokines in innate host defense in the lung. The Journal of Clinical Investigation 2002 109 6 699 705 2-s2.0-0036196346 10.1172/JCI200215277 (Pubitemid 34263143)
127. Palladino M. A., Bahjat F. R., Theodorakis E. A., Moldawer L. L., Anti-TNF- α therapies: the next generation. Nature Reviews Drug Discovery 2003 2 9 736 746 2-s2.0-0142058174
128. Mehrad B., Strieter R. M., Moore T. A., Tsai W. C., Lira S. A., Standiford T. J., CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. The Journal of Immunology 1999 163 11 6086 6094 2-s2.0-0033485741
129. Cenci E., Mencacci A., D'Ostiani C. F., Del Sero G., Mosci P., Montagnoli C., Bacci A., Romani L., Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. The Journal of Infectious Diseases 1998 178 6 1750 1760 2-s2.0-0031768272 10.1086/314493 (Pubitemid 28558149)
130. Brieland J. K., Jackson C., Menzel F., Loebenberg D., Cacciapuoti A., Halpern J., Hurst S., Muchamuel T., Debets R., Kastelein R., Churakova T., Abrams J., Hare R., O'Garra A., Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infection and Immunity 2001 69 3 1554 1560 2-s2.0-0035114999 10.1128/IAI.69.3.1554-1560.2001 (Pubitemid 32187608)
131. Armstrong-James D. P. H., Turnbull S. A., Teo I., Stark J., Rogers N. J., Rogers T. R. F., Bignell E., Haynes K., Impaired interferon- γ responses, increased interleukin-17 expression, and a tumor necrosis factor- α transcriptional program in invasive aspergillosis. The Journal of Infectious Diseases 2009 200 8 1341 1351 2-s2.0-70349433733 10.1086/605931
132. Tsiodras S., Samonis G., Boumpas D. T., Kontoyiannis D. P., Fungal infections complicating tumor necrosis factor α blockade therapy. Mayo Clinic Proceedings 2008 83 2 181 194 2-s2.0-39749102391 10.4065/83.2.181 (Pubitemid 351303102)
133. Rychly D. J., DiPiro J. T., Infections associated with tumor necrosis factor- α antagonists. Pharmacotherapy 2005 25 9 1181 1192 2-s2.0-24144456554 10.1592/phco.2005.25.9.1181 (Pubitemid 41242578)
134. Filler S. G., Yeaman M. R., Sheppard D. C., Tumor necrosis factor inhibition and invasive fungal infections. Clinical Infectious Diseases 2005 41 supplement 3 S208 S212 2-s2.0-22544445912 10.1086/430000 (Pubitemid 41022093)
135. Roilides E., Dimitriadou-Georgiadou A., Sein T., Kadiltsoglou I., Walsh T. J., Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infection and Immunity 1998 66 12 5999 6003 2-s2.0-0031741636 (Pubitemid 28531864)
136. Gamble J. R., Harlan J. M., Klebanoff S. J., Vadas M. A., Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proceedings of the National Academy of Sciences of the United States of America 1985 82 24 8667 8671 2-s2.0-0142164496 (Pubitemid 16101104)
137. Zlotnik A., Yoshie O., Chemokines: a new classification system and their role in immunity. Immunity 2000 12 2 121 127 2-s2.0-0034144269 (Pubitemid 30398626)
138. Gafa V., Remoli M. E., Giacomini E., Gagliardi M. C., Lande R., Severa M., Grillot R., Coccia E. M., In vitro infection of human dendritic cells by Aspergillus fumigatus conidia triggers the secretion of chemokines for neutrophil and Th1 lymphocyte recruitment. Microbes and Infection 2007 9 8 971 980 2-s2.0-34250677730 10.1016/j.micinf.2007.03.015 (Pubitemid 46929097)
139. Bellanger A.-P., Millon L., Khoufache K., Rivollet D., Bièche I., Laurendeau I., Vidaud M., Botterel F., Bretagne S., Aspergillus fumigatus germ tube growth and not conidia ingestion induces expression of inflammatory mediator genes in the human lung epithelial cell line A549. Journal of Medical Microbiology 2009 58 2 174 179 2-s2.0-59949090500 10.1099/jmm.0.005488-0
140. Cortez K. J., Lyman C. A., Kottilil S., Kim H. S., Roilides E., Yang J., Fullmer B., Lempicki R., Walsh T. J., Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infection and Immunity 2006 74 4 2353 2365 2-s2.0-33645508930 10.1128/IAI.74.4.2353-2365.2006
141. Pylkkänen L., Gullstén H., Majuri M.-L., Exposure to Aspergillus fumigatus spores induces chemokine expression in mouse macrophages. Toxicology 2004 200 2-3 255 263 10.1016/j.tox.2004.03.019 (Pubitemid 38798435)
142. Shahan T. A., Sorenson W. G., Paulauskis J. D., Morey R., Lewis D. M., Concentration- and time-dependent upregulation and release of the cytokines MIP-2, KC, TNF, and MIP-1 α in rat alveolar macrophages by fungal spores implicated in airway inflammation. American Journal of Respiratory Cell and Molecular Biology 1998 18 3 435 440 2-s2.0-0032012974 (Pubitemid 128354102)
143. Kamai Y., Lossinsky A. S., Liu H., Sheppard D. C., Filler S. G., Polarized response of endothelial cells to invasion by Aspergillus fumigatus. Cellular Microbiology 2009 11 1 170 182 2-s2.0-58149295153 10.1111/j.1462-5822. 2008.01247.x
144. Mehrad B., Wiekowski M., Morrison B. E., Chen S.-G., Coronel E. C., Manfra D. J., Lira S. A., Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. American Journal of Respiratory and Critical Care Medicine 2002 166 9 1263 1268 2-s2.0-0036839864 10.1164/rccm.200204-367OC (Pubitemid 35222605)
145. Park S. J., Hughes M. A., Burdick M., Strieter R. M., Mehrad B., Early NK cell-derived IFN- γ is essential to host defense in neutropenic invasive aspergillosis. The Journal of Immunology 2009 182 7 4306 4312 2-s2.0-64249134349 10.4049/jimmunol.0803462
146. Mehrad B., Moore T. A., Standiford T. J., Macrophage inflammatory protein-1 α is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. The Journal of Immunology 2000 165 2 962 968 2-s2.0-0034662240 (Pubitemid 30484765)
147. Morrison B. E., Park S. J., Mooney J. M., Mehrad B., Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. The Journal of Clinical Investigation 2003 112 12 1862 1870 2-s2.0-0346059732 10.1172/JCI200318125 (Pubitemid 38063709)
148. Blease K., Mehrad B., Lukacs N. W., Kunkel S. L., Standiford T. J., Hogaboam C. M., Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. The Journal of Immunology 2001 166 3 1832 1842 2-s2.0-0035253603 (Pubitemid 32114669)
149. Phadke A. P., Akangire G., Park S. J., Lira S. A., Mehrad B., The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. American Journal of Respiratory and Critical Care Medicine 2007 175 11 1165 1172 2-s2.0-34249805431 10.1164/rccm.200602-256OC (Pubitemid 46855458)
150. Park S. J., Burdick M. D., Brix W. K., Stoler M. H., Askew D. S., Strieter R. M., Mehrad B., Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loop. The Journal of Immunology 2010 185 10 6190 6197 2-s2.0-78650658958 10.4049/jimmunol.1002064
151. Carpenter K. J., Hogaboam C. M., Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis. Infection and Immunity 2005 73 11 7198 7207 2-s2.0-27744503985 10.1128/IAI.73.11.7198-7207.2005 (Pubitemid 41587617)
152. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. The Journal of Immunology 2005 175 1 5 14 2-s2.0-23944493698
153. Cenci E., Perito S., Enssle K. H., Mosci P., Latgé J.-P., Romani L., Bistoni F., Th1 and Th2 cytokines in mice with invasive aspergillosis. Infection and Immunity 1997 65 2 564 570 2-s2.0-0031027462 (Pubitemid 27053226)
154. Cenci E., Mencacci A., Del Sero G., Bacci A., Montagnoli C., D'Ostiani C. F., Mosci P., Bachmann M., Bistoni F., Kopf M., Romani L., Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. The Journal of Infectious Diseases 1999 180 6 1957 1968 2-s2.0-0032750427 10.1086/315142
155. Gaviria J. M., van Burik J. A., Dale D. C., Root R. K., Liles W. C., Comparison of interferon- γ granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte- mediated hyphal damage of opportunistic fungal pathogens. The Journal of Infectious Diseases 1999 179 4 1038 1041 2-s2.0-0032902415 10.1086/314679 (Pubitemid 29159356)
156. Roilides E., Uhlig K., Venzon D., Pizzo P. A., Walsh T. J., Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infection and Immunity 1993 61 4 1185 1193 2-s2.0-0027417226 (Pubitemid 23099183)
157. Roilides E., Holmes A., Blake C., Venzon D., Pizzo P. A., Walsh T. J., Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon- γ The Journal of Infectious Diseases 1994 170 4 894 899 2-s2.0-0027981993 (Pubitemid 24296569)
158. Gil-Lamaignere C., Winn R. M., Simitsopoulou M., Maloukou A., Walsh T. J., Roilides E., Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp. Medical Mycology 2005 43 3 253 260 2-s2.0-20944444512 10.1080/13693780412331271072 (Pubitemid 40867499)
159. Brummer E., Maqbool A., Stevens D. A., In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages. Journal of Leukocyte Biology 2001 70 6 868 872 2-s2.0-0035217135 (Pubitemid 33151125)
160. Vora S., Chauhan S., Brummer E., Stevens D. A., Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Antimicrobial Agents and Chemotherapy 1998 42 9 2299 2303 2-s2.0-0031713711 (Pubitemid 28420368)
161. Bouzani M., Ok M., McCormick A., Ebel F., Kurzai O., Morton C. O., Einsele H., Loeffler J., Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN- γ release. The Journal of Immunology 2011 187 3 1369 1376 2-s2.0-80051657716 10.4049/jimmunol.1003593
162. Asadullah K., Sterry W., Volk H. D., Interleukin-10 therapy-review of a new approach. Pharmacological Reviews 2003 55 2 241 269 2-s2.0-0038283161 10.1124/pr.55.2.4 (Pubitemid 36666048)
163. Roilides E., Sein T., Roden M., Schaufele R. L., Walsh T. J., Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis. The Journal of Infectious Diseases 2001 183 3 518 520 2-s2.0-0035253289 10.1086/318077 (Pubitemid 32105614)
164. Roilides E., Dimitriadou A., Kadiltsoglou I., Sein T., Karpouzas J., Pizzo P. A., Walsh T. J., IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. The Journal of Immunology 1997 158 1 322 329 2-s2.0-0030639089 (Pubitemid 127483872)
165. Clemons K. V., Grunig G., Sobel R. A., Mirels L. F., Rennick D. M., Stevens D. A., Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clinical and Experimental Immunology 2000 122 2 186 191 2-s2.0-0033732650 10.1046/j.1365-2249.2000.01382.x
166. Hohne K., Schliessmann S. J., Kirschbaum A., Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type II. PLoS ONE 2012 7 7 e38369 10.1371/journal.pone.0038369
167. Lupetti A., van Dissel J. T., Brouwer C. P. J. M., Nibbering P. H., Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus. European Journal of Clinical Microbiology and Infectious Diseases 2008 27 11 1125 1129 2-s2.0-55549110379 10.1007/s10096-008-0553-z
168. Bergsson G., Reeves E. P., McNally P., Chotirmall S. H., Greene C. M., Greally P., Murphy P., O'Neill S. J., McElvaney N. G., LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. The Journal of Immunology 2009 183 1 543 551 2-s2.0-68949117860 10.4049/jimmunol.0803959
169. Gibbons A. M., McElvaney N. G., Taggart C. C., Cryan S.-A., Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation. Journal of Microencapsulation 2009 26 6 513 522 2-s2.0-70849090983 10.1080/02652040802466535
170. Bandera A., Trabattoni D., Ferrario G., Cesari M., Franzetti F., Clerici M., Gori A., Interferon- γ and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis. Infection 2008 36 4 368 373 2-s2.0-50649096799 10.1007/s15010-008-7378-7